| Aging, Elder Care, and Social Issues | Lifetime | 3 | FR 1 | 99.53 |
| Frailty in Older Adults | Lifetime | 6 | FR 1 | 99.90 |
| Nutrition and Health in Aging | Lifetime | 12 | FR 1 | 99.92 |
| Health, Medicine and Society | Lifetime | 25 | FR 14 | 98.55 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 51 | FR 2 | 99.79 |
| Dementia and Cognitive Impairment Research | Lifetime | 47 | FR 3 | 99.83 |
| Alzheimer's disease research and treatments | Lifetime | 141 | FR 3 | 99.61 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 149 | FR 9 | 98.68 |
| GDF15 and Related Biomarkers | Lifetime | 39 | FR 1 | 97.26 |
| Nutritional Studies and Diet | Lifetime | 407 | FR 13 | 98.59 |
| Folate and B Vitamins Research | Lifetime | 323 | FR 5 | 97.30 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 250 | FR 11 | 97.99 |
| Body Composition Measurement Techniques | Lifetime | 221 | FR 6 | 97.78 |
| Ginkgo biloba and Cashew Applications | Lifetime | 70 | FR 2 | 96.89 |
| Geriatric Care and Nursing Homes | Lifetime | 521 | FR 3 | 96.61 |
| Health, Environment, Cognitive Aging | Lifetime | 303 | FR 12 | 95.78 |
| Balance, Gait, and Falls Prevention | Lifetime | 679 | FR 19 | 95.53 |
| Chronic Disease Management Strategies | Lifetime | 981 | FR 4 | 94.91 |
| Frailty in Older Adults | 2021-2025 | 2 | FR 1 | 99.73 |
| Nutrition and Health in Aging | 2021-2025 | 25 | FR 2 | 99.46 |
| GDF15 and Related Biomarkers | 2021-2025 | 3 | FR 1 | 96.41 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 93 | FR 2 | 98.58 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 87 | FR 1 | 99.08 |
| Alzheimer's disease research and treatments | 2021-2025 | 511 | FR 18 | 94.45 |
| Aging, Elder Care, and Social Issues | 2021-2025 | 68 | FR 17 | 85.24 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 204 | FR 2 | 88.75 |
| Health, Medicine and Society | 2021-2025 | 152 | FR 108 | 84.10 |
| Genetics, Aging, and Longevity in Model Organisms | 2021-2025 | 334 | FR 8 | 83.90 |
